Rabies Vaccine Industry Research Report 2024

Rabies Vaccine Industry Research Report 2024


Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

According to APO Research, the global Rabies Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.

The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen

Rabies Vaccine segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Rabies Vaccine segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis

Rabies Vaccine Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rabies Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Rabies Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Rabies Vaccine Sales (2019-2030)
2.2.3 Global Rabies Vaccine Market Average Price (2019-2030)
2.3 Rabies Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Vero Cell Rabies Vaccine
2.3.3 BHK
2.3.4 Chick Embryo Cell Rabies Vaccine
2.3.5 Others
2.4 Rabies Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Pre-exposure Prophylaxis
2.4.3 Post-exposure Prophylaxis
3 Market Competitive Landscape by Manufacturers
3.1 Global Rabies Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Rabies Vaccine Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Rabies Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Rabies Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Rabies Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Rabies Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Rabies Vaccine, Product Type & Application
3.8 Global Manufacturers of Rabies Vaccine, Date of Enter into This Industry
3.9 Global Rabies Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 GSK (Novartis)
4.1.1 GSK (Novartis) Company Information
4.1.2 GSK (Novartis) Business Overview
4.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
4.1.5 GSK (Novartis) Recent Developments
4.2 Sanofi-Pasteur
4.2.1 Sanofi-Pasteur Company Information
4.2.2 Sanofi-Pasteur Business Overview
4.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
4.2.5 Sanofi-Pasteur Recent Developments
4.3 Chengda
4.3.1 Chengda Company Information
4.3.2 Chengda Business Overview
4.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Chengda Rabies Vaccine Product Portfolio
4.3.5 Chengda Recent Developments
4.4 Yisheng
4.4.1 Yisheng Company Information
4.4.2 Yisheng Business Overview
4.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Yisheng Rabies Vaccine Product Portfolio
4.4.5 Yisheng Recent Developments
4.5 Prcmise
4.5.1 Prcmise Company Information
4.5.2 Prcmise Business Overview
4.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Prcmise Rabies Vaccine Product Portfolio
4.5.5 Prcmise Recent Developments
4.6 VACN
4.6.1 VACN Company Information
4.6.2 VACN Business Overview
4.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 VACN Rabies Vaccine Product Portfolio
4.6.5 VACN Recent Developments
4.7 Changsheng
4.7.1 Changsheng Company Information
4.7.2 Changsheng Business Overview
4.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Changsheng Rabies Vaccine Product Portfolio
4.7.5 Changsheng Recent Developments
4.8 BCHT
4.8.1 BCHT Company Information
4.8.2 BCHT Business Overview
4.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 BCHT Rabies Vaccine Product Portfolio
4.8.5 BCHT Recent Developments
4.9 Hissen
4.9.1 Hissen Company Information
4.9.2 Hissen Business Overview
4.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Hissen Rabies Vaccine Product Portfolio
4.9.5 Hissen Recent Developments
5 Global Rabies Vaccine Market Scenario by Region
5.1 Global Rabies Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Rabies Vaccine Sales by Region: 2019-2030
5.2.1 Global Rabies Vaccine Sales by Region: 2019-2024
5.2.2 Global Rabies Vaccine Sales by Region: 2025-2030
5.3 Global Rabies Vaccine Revenue by Region: 2019-2030
5.3.1 Global Rabies Vaccine Revenue by Region: 2019-2024
5.3.2 Global Rabies Vaccine Revenue by Region: 2025-2030
5.4 North America Rabies Vaccine Market Facts & Figures by Country
5.4.1 North America Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Rabies Vaccine Sales by Country (2019-2030)
5.4.3 North America Rabies Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Rabies Vaccine Market Facts & Figures by Country
5.5.1 Europe Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Rabies Vaccine Sales by Country (2019-2030)
5.5.3 Europe Rabies Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Rabies Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Rabies Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Rabies Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Rabies Vaccine Market Facts & Figures by Country
5.7.1 Latin America Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Rabies Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Rabies Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Rabies Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Rabies Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Rabies Vaccine Sales by Type (2019-2030)
6.1.1 Global Rabies Vaccine Sales by Type (2019-2030) & (K Units)
6.1.2 Global Rabies Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Rabies Vaccine Revenue by Type (2019-2030)
6.2.1 Global Rabies Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Rabies Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Rabies Vaccine Price by Type (2019-2030)
7 Segment by Application
7.1 Global Rabies Vaccine Sales by Application (2019-2030)
7.1.1 Global Rabies Vaccine Sales by Application (2019-2030) & (K Units)
7.1.2 Global Rabies Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Rabies Vaccine Revenue by Application (2019-2030)
7.2.1 Global Rabies Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Rabies Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Rabies Vaccine Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Rabies Vaccine Value Chain Analysis
8.1.1 Rabies Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Rabies Vaccine Production Mode & Process
8.2 Rabies Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Rabies Vaccine Distributors
8.2.3 Rabies Vaccine Customers
9 Global Rabies Vaccine Analyzing Market Dynamics
9.1 Rabies Vaccine Industry Trends
9.2 Rabies Vaccine Industry Drivers
9.3 Rabies Vaccine Industry Opportunities and Challenges
9.4 Rabies Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings